PRLog - Feb. 27, 2013 - BASEL CITY, Switzerland -- SFL is pleased to announce its participation at the 25th DIA Annual EuroMeeting in Amsterdam, 4-6 March 2013. This year’s meeting will feature over 110 sessions and is expected to attract more than 3,000 professionals involved in the development of medicines from more than 50 countries. As in previous years, SFL’s team is heavily involved in the DIA meeting, serving as a Member of the DIA EuroMeeting Program Committee.
On Tuesday 5 March 2013 morning, Shayesteh Fürst- Ladani, SFL’s Managing Director, will be chairing the session “Current Status of Revision of EU Medical Devices Directives”. This session will assess key developments and present the positions of stakeholders, including industry, at a time when the proposals are debated by the European Parliament and later the Council of the EU. She will be presenting an overview on the revision of medical devices and In Vitro Diagnostics Directives.
Amanda Maxwell, Head of the UK office of SFL, will be chairing and speaking in the Tuesday morning session on EU approval of drug/device combinations, the new regulatory structure and how it will impact innovation. Samantha Regenthal, Head Legal Services at SFL, will be chairing and speaking a session on legal compliance for regulatory functions, highlighting learnings from recent legal cases and other enforcement activities. On Wednesday 6 March, Anna Hallersten, SFL’s Public Affairs Director will present on the role of Ethics Committees in the proposed Clinical Trial Regulation.
Outside the main sessions, attendees can also meet the SFL team at the company’ exhibition booth (#613). The team will be happy to answer questions and provide further information on the company’s expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications. If you would like to arrange a meeting in advance, please send us an email at email@example.com.
About SFL Regulatory Affairs & Scientific Communication Ltd
SFL is dedicated to a holistic approach to lifecycle management of healthcare products from nonclinical and clinical studies through to registration and post-approval activities. The SFL team members have experience in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications, and provide personalized and comprehensive services. When combined, these services comprise an integral oversight package for products from the bench to the marketplace at one consultancy. SFL also provides specialized training courses where participants can benefit from the team’s cross-functional expertise.